Biotech · Private company · Paramus, NJ, US
Psychogenics, Inc.
Track this companyFree. Adds Psychogenics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards9
- TAAR1 Agonists for the Treatment of Stimulant Use DisorderFiscal year 2026 · $398.9KNIH RePORTER 1R43DA061847-01A1 · fetched Nov 12, 2026
- EEG Signature Analysis for Drug Repurposing for Rare DiseasesFiscal year 2026 · $924KNIH RePORTER 4R44MH138151-03 · fetched Nov 12, 2026
- SCREENING OF INVESTIGATIONAL AGENTS THROUGH THE NINDS PRECLINICAL SCREENING PLATFORM FOR PAIN (PSPP)Fiscal year 2026 · $14.8MNIH RePORTER 75N95024D00038-P00002-759502400001-1 · fetched Nov 12, 2026
- Development of a Drug Candidate for the Treatment of Agitation in Alzheimer's DiseaseFiscal year 2025 · $495.7KNIH RePORTER 1R44AG090144-01A1 · fetched Nov 12, 2026
- EEG Signature Analysis for Drug Repurposing for Rare DiseasesFiscal year 2025 · $460.2KNIH RePORTER 5R44MH138151-02 · fetched Nov 12, 2026
- SCREENING OF INVESTIGATIONAL AGENTS THROUGH THE NINDS PRECLINICAL SCREENING PLATFORM FOR PAIN (PSPP)Fiscal year 2025 · $9.5MNIH RePORTER 75N95024D00038-P00001-759502400001-1 · fetched Nov 12, 2026
- EEG Signature Analysis for Drug Repurposing for Rare DiseasesFiscal year 2024 · $560.6KNIH RePORTER 1R44MH138151-01 · fetched Nov 12, 2026
- Machine Learning Phenotypic De Novo Drug DesignFiscal year 2024 · $499.9KNIH RePORTER 5R43MH134716-02 · fetched Nov 12, 2026
- SCREENING OF INVESTIGATIONAL AGENTS THROUGH THE NINDS PRECLINICAL SCREENING PLATFORM FOR PAIN (PSPP)Fiscal year 2024 · $11.8MNIH RePORTER 75N95024D00038-0-759502400001-1 · fetched Nov 12, 2026